BR112015002984A2 - composição, vacina para proteger um animal contra uma infecção com bactérias leptospira, e, uso de ácido cítrico. - Google Patents
composição, vacina para proteger um animal contra uma infecção com bactérias leptospira, e, uso de ácido cítrico.Info
- Publication number
- BR112015002984A2 BR112015002984A2 BR112015002984A BR112015002984A BR112015002984A2 BR 112015002984 A2 BR112015002984 A2 BR 112015002984A2 BR 112015002984 A BR112015002984 A BR 112015002984A BR 112015002984 A BR112015002984 A BR 112015002984A BR 112015002984 A2 BR112015002984 A2 BR 112015002984A2
- Authority
- BR
- Brazil
- Prior art keywords
- vaccine
- protect
- composition
- citric acid
- against infection
- Prior art date
Links
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 title 3
- 241000589902 Leptospira Species 0.000 title 1
- 208000015181 infectious disease Diseases 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0225—Spirochetes, e.g. Treponema, Leptospira, Borrelia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP12180792 | 2012-08-17 | ||
PCT/EP2013/067132 WO2014027083A1 (en) | 2012-08-17 | 2013-08-16 | An immunogenic composition of killed leptospira bacteria |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112015002984A2 true BR112015002984A2 (pt) | 2018-06-12 |
Family
ID=48986146
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112015002984A BR112015002984A2 (pt) | 2012-08-17 | 2013-08-16 | composição, vacina para proteger um animal contra uma infecção com bactérias leptospira, e, uso de ácido cítrico. |
Country Status (11)
Country | Link |
---|---|
US (1) | US9375480B2 (pt) |
EP (1) | EP2884996B1 (pt) |
JP (1) | JP6502849B2 (pt) |
CN (1) | CN104582719B (pt) |
AU (1) | AU2013304048B2 (pt) |
BR (1) | BR112015002984A2 (pt) |
DK (1) | DK2884996T3 (pt) |
ES (1) | ES2772451T3 (pt) |
PT (1) | PT2884996T (pt) |
RU (1) | RU2667642C2 (pt) |
WO (1) | WO2014027083A1 (pt) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023247622A1 (en) * | 2022-06-22 | 2023-12-28 | Intervet International B.V. | Vaccine for protection against leptospira serovar icterohaemorrhagiae |
WO2023247613A1 (en) * | 2022-06-22 | 2023-12-28 | Intervet International B.V. | Vaccine for protection against leptospira serovar australis |
WO2023247619A1 (en) * | 2022-06-22 | 2023-12-28 | Intervet International B.V. | Vaccine for protection against leptospira serovar grippotyphosa |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3184384A (en) * | 1961-09-07 | 1965-05-18 | Dow Chemical Co | Method of producing brucella abortus vaccine |
DE69322268T2 (de) * | 1992-04-30 | 1999-08-05 | Cor Therapeutics Inc | Stabile zusammensetzung von polypeptiden |
US5925354A (en) * | 1995-11-30 | 1999-07-20 | Michigan State University | Riboflavin mutants as vaccines against Actinobacillus pleuropneumoniae |
US20050089533A1 (en) * | 2003-01-29 | 2005-04-28 | Joseph Frantz | Canine vaccines against Bordetella bronchiseptica |
JPWO2005063291A1 (ja) * | 2003-12-25 | 2007-07-19 | 麒麟麦酒株式会社 | 抗体を含有する安定な水性医薬製剤 |
PE20100366A1 (es) * | 2008-10-24 | 2010-05-21 | Panacea Biotec Ltd | Novedosas composiciones de vacuna con tos ferina acelular asi como el metodo para su elaboracion |
BRPI0923006A2 (pt) * | 2008-12-17 | 2016-03-08 | Novartis Ag | vacinas meningococicas incluindo receptor de hemoglobina |
US8546149B2 (en) * | 2010-08-27 | 2013-10-01 | Intervet Inc. | Potency test for vaccine formulations |
CA2809758C (en) * | 2010-09-10 | 2021-07-13 | Wyeth Llc | Non-lipidated variants of neisseria meningitidis orf2086 antigens |
-
2013
- 2013-08-16 EP EP13750074.0A patent/EP2884996B1/en active Active
- 2013-08-16 BR BR112015002984A patent/BR112015002984A2/pt active Search and Examination
- 2013-08-16 PT PT137500740T patent/PT2884996T/pt unknown
- 2013-08-16 JP JP2015526999A patent/JP6502849B2/ja active Active
- 2013-08-16 US US14/420,944 patent/US9375480B2/en active Active
- 2013-08-16 WO PCT/EP2013/067132 patent/WO2014027083A1/en active Application Filing
- 2013-08-16 CN CN201380044246.2A patent/CN104582719B/zh active Active
- 2013-08-16 RU RU2015109124A patent/RU2667642C2/ru not_active IP Right Cessation
- 2013-08-16 ES ES13750074T patent/ES2772451T3/es active Active
- 2013-08-16 DK DK13750074.0T patent/DK2884996T3/da active
- 2013-08-16 AU AU2013304048A patent/AU2013304048B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
DK2884996T3 (da) | 2020-03-09 |
CN104582719B (zh) | 2017-09-15 |
ES2772451T3 (es) | 2020-07-07 |
US9375480B2 (en) | 2016-06-28 |
AU2013304048B2 (en) | 2018-03-01 |
US20150216976A1 (en) | 2015-08-06 |
RU2667642C2 (ru) | 2018-09-21 |
JP2015530372A (ja) | 2015-10-15 |
EP2884996A1 (en) | 2015-06-24 |
CN104582719A (zh) | 2015-04-29 |
RU2015109124A (ru) | 2016-10-10 |
PT2884996T (pt) | 2020-02-21 |
JP6502849B2 (ja) | 2019-04-17 |
EP2884996B1 (en) | 2020-01-08 |
AU2013304048A1 (en) | 2015-02-05 |
WO2014027083A1 (en) | 2014-02-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3061454T3 (da) | Parasitiske orale veterinærsammensætninger omfattende systemisk-virkende aktivstoffer, fremgangsmåder og anvendelser deraf | |
BR112015003376A8 (pt) | composto ou sal farmaceuticamente aceitável do mesmo, composição farmacêutica e usos de quantidade eficiente de composto ou sal farmaceuticamente aceitável do mesmo ou composição farmacêutica | |
EA201591004A1 (ru) | Производные бороновой кислоты и их терапевтическое применение | |
DK2912074T4 (da) | Dermal injicerbar steril sammensætning | |
EA201691988A1 (ru) | Производные бороновой кислоты и их терапевтическое применение | |
CL2014000470A1 (es) | Compuestos derivados del acido 2-oxo-piridin-3-carboxilico; composicion farmaceutica; combinacion; y su uso para tratar o mejorar una infeccion bacteriana. | |
BR112012022878A2 (pt) | composto, composição farmacêutica, uso do compostos e método de tratamento | |
MX2016008448A (es) | Conjugados de var2csa-farmaco. | |
EA201992133A1 (ru) | Производные пиперидино-пиримидина для лечения вирусных инфекций | |
HK1198921A1 (en) | Antimicrobial compositions comprising dgla, 15-ohepa and/or 15-hetre and methods of use thereof dgla15-ohepa / 15-hetre | |
HK1202415A1 (en) | Pharmaceutical compositions comprising dgla, 15-ohepa, and/or 15- hetre and methods of use thereof dgla15-ohepa/ 15-hetre | |
BR112012022879A2 (pt) | composto, composição farmacêutica, uso do composto e método de tratamento | |
BR112014014078A8 (pt) | composições compreendendo constructos genéticos il-12 aperfeiçoados e vacinas, imunoterapêuticos e métodos de uso dos mesmos | |
DK3281607T3 (da) | Implanterbar protese med acellulære vævsvedhæftninger. | |
BR112014010290A2 (pt) | composição farmacêutica, métodos, composições e usos | |
BR112013022556A8 (pt) | composição farmacêutica aquosa semissólida contendo tapentadol, seu uso e uso de tapentadol | |
CL2014003113A1 (es) | Composición que comprende bacterias inactivadas de alliivibrio wodanis; método de producción; uso para fabricar medicamento para tratar y/o prevenir wodanosis; y vacuna para peces. | |
BR112013023575A8 (pt) | novo derivado de octaidrotienoquinolina, composição farmacêutica compreendendo derivado, e uso destes | |
BR112015002984A2 (pt) | composição, vacina para proteger um animal contra uma infecção com bactérias leptospira, e, uso de ácido cítrico. | |
BR112015003074A2 (pt) | composição, vacina para proteger um animal contra uma infecção com bactérias leptospira, e, uso de ácido etilenodiaminatetra-acético. | |
CN105682672A8 (zh) | 含有来自毛泡桐的香叶基黄酮作为有效成分的用于抑制神经氨酸酶活性的组合物 | |
BR112015006272A2 (pt) | ''uso cosmético, composto, composição cosmética e método de tratamento cosmético'' | |
BR112015002727A2 (pt) | combinação, uso de uma combinação, composição farmacêutica, uso de uma composição farmacêutica, kit, e, método para tratamento de uma infecção ou doença relacionada a tal infecção em humanos ou animais. | |
BR112015002726A2 (pt) | combinação, uso de uma combinação, composição farmacêutica, uso de uma composição farmacêutica, kit, e método de tratamento de uma infecção ou doença relacionada a tal infecção em humanos ou animais. | |
BR112013033522A2 (pt) | composição aquosa, composição injetável, polímero de ácido acrílico, e, uso de um polímero de ácido acrílico |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B11D | Dismissal acc. art. 38, par 2 of ipl - failure to pay fee after grant in time | ||
B350 | Update of information on the portal [chapter 15.35 patent gazette] |